Titre : Sondes d'acide nucléique

Sondes d'acide nucléique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Transfusion
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sondes d'acide nucléique : Questions médicales les plus fréquentes", "headline": "Sondes d'acide nucléique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sondes d'acide nucléique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-17", "dateModified": "2025-05-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sondes d'acide nucléique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sondes moléculaires", "url": "https://questionsmedicales.fr/mesh/D015335", "about": { "@type": "MedicalCondition", "name": "Sondes moléculaires", "code": { "@type": "MedicalCode", "code": "D015335", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Éléments antisens (génétique)", "alternateName": "Antisense Elements (Genetics)", "url": "https://questionsmedicales.fr/mesh/D016375", "about": { "@type": "MedicalCondition", "name": "Éléments antisens (génétique)", "code": { "@type": "MedicalCode", "code": "D016375", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ADN antisens", "alternateName": "DNA, Antisense", "url": "https://questionsmedicales.fr/mesh/D016373", "about": { "@type": "MedicalCondition", "name": "ADN antisens", "code": { "@type": "MedicalCode", "code": "D016373", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.200" } } }, { "@type": "MedicalWebPage", "name": "Oligonucléotides antisens", "alternateName": "Oligonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D016376", "about": { "@type": "MedicalCondition", "name": "Oligonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D016376", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oligodésoxyribonucléotides antisens", "alternateName": "Oligodeoxyribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020319", "about": { "@type": "MedicalCondition", "name": "Oligodésoxyribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640.640" } } } ] }, { "@type": "MedicalWebPage", "name": "Oligodésoxyribonucléotides antisens", "alternateName": "Oligodeoxyribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020319", "about": { "@type": "MedicalCondition", "name": "Oligodésoxyribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020319", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.640.640" } } }, { "@type": "MedicalWebPage", "name": "ARN antisens", "alternateName": "RNA, Antisense", "url": "https://questionsmedicales.fr/mesh/D016372", "about": { "@type": "MedicalCondition", "name": "ARN antisens", "code": { "@type": "MedicalCode", "code": "D016372", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Oligoribonucléotides antisens", "alternateName": "Oligoribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020320", "about": { "@type": "MedicalCondition", "name": "Oligoribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760.645" } } } ] }, { "@type": "MedicalWebPage", "name": "Oligoribonucléotides antisens", "alternateName": "Oligoribonucleotides, Antisense", "url": "https://questionsmedicales.fr/mesh/D020320", "about": { "@type": "MedicalCondition", "name": "Oligoribonucléotides antisens", "code": { "@type": "MedicalCode", "code": "D020320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.150.760.645" } } } ] }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN", "alternateName": "DNA Probes", "url": "https://questionsmedicales.fr/mesh/D015342", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN", "code": { "@type": "MedicalCode", "code": "D015342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ADN complémentaire", "alternateName": "DNA, Complementary", "url": "https://questionsmedicales.fr/mesh/D018076", "about": { "@type": "MedicalCondition", "name": "ADN complémentaire", "code": { "@type": "MedicalCode", "code": "D018076", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.260" } } }, { "@type": "MedicalWebPage", "name": "Amorces ADN", "alternateName": "DNA Primers", "url": "https://questionsmedicales.fr/mesh/D017931", "about": { "@type": "MedicalCondition", "name": "Amorces ADN", "code": { "@type": "MedicalCode", "code": "D017931", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.600" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN spécifiques des gènes HLA", "alternateName": "DNA Probes, HLA", "url": "https://questionsmedicales.fr/mesh/D015343", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN spécifiques des gènes HLA", "code": { "@type": "MedicalCode", "code": "D015343", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.615" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ADN spécifiques du VPH", "alternateName": "DNA Probes, HPV", "url": "https://questionsmedicales.fr/mesh/D015344", "about": { "@type": "MedicalCondition", "name": "Sondes d'ADN spécifiques du VPH", "code": { "@type": "MedicalCode", "code": "D015344", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.223.620" } } } ] }, { "@type": "MedicalWebPage", "name": "Sondes oligonucléotidiques", "alternateName": "Oligonucleotide Probes", "url": "https://questionsmedicales.fr/mesh/D015345", "about": { "@type": "MedicalCondition", "name": "Sondes oligonucléotidiques", "code": { "@type": "MedicalCode", "code": "D015345", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.650" } } }, { "@type": "MedicalWebPage", "name": "Sondes d'ARN", "alternateName": "RNA Probes", "url": "https://questionsmedicales.fr/mesh/D015347", "about": { "@type": "MedicalCondition", "name": "Sondes d'ARN", "code": { "@type": "MedicalCode", "code": "D015347", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.825" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "ARN complémentaire", "alternateName": "RNA, Complementary", "url": "https://questionsmedicales.fr/mesh/D018075", "about": { "@type": "MedicalCondition", "name": "ARN complémentaire", "code": { "@type": "MedicalCode", "code": "D018075", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.470.530.600.825.840" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Sondes d'acide nucléique", "alternateName": "Nucleic Acid Probes", "code": { "@type": "MedicalCode", "code": "D015341", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Na Li", "url": "https://questionsmedicales.fr/author/Na%20Li", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China." } }, { "@type": "Person", "name": "Ru Sun", "url": "https://questionsmedicales.fr/author/Ru%20Sun", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China." } }, { "@type": "Person", "name": "Yu-Jie Xu", "url": "https://questionsmedicales.fr/author/Yu-Jie%20Xu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, 215123, Suzhou, China." } }, { "@type": "Person", "name": "Jian-Feng Ge", "url": "https://questionsmedicales.fr/author/Jian-Feng%20Ge", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Material Science, Soochow University, 199 Ren'Ai Road, 215123, Suzhou, China. ge_jianfeng@hotmail.com." } }, { "@type": "Person", "name": "Bo Tang", "url": "https://questionsmedicales.fr/author/Bo%20Tang", "affiliation": { "@type": "Organization", "name": "College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, P. R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes.", "datePublished": "2023-07-15", "url": "https://questionsmedicales.fr/article/37452616", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ejh.14049" } }, { "@type": "ScholarlyArticle", "name": "The appropriateness of platelet transfusions in hematological patients and the potential for improvement.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36493919", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.tracli.2022.11.007" } }, { "@type": "ScholarlyArticle", "name": "Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Two case reports.", "datePublished": "2023-02-15", "url": "https://questionsmedicales.fr/article/36805153", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.transci.2023.103658" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of the Association of Platelet Count, Mean Platelet Volume, and Platelet Transfusion With Intraventricular Hemorrhage and Death Among Preterm Infants.", "datePublished": "2022-10-03", "url": "https://questionsmedicales.fr/article/36260331", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2022.37588" } }, { "@type": "ScholarlyArticle", "name": "Immunologic effects of red blood cell and platelet transfusions in neonates.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36165536", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MOH.0000000000000736" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://questionsmedicales.fr/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Produits chimiques de laboratoire", "item": "https://questionsmedicales.fr/mesh/D019995" }, { "@type": "ListItem", "position": 5, "name": "Sondes moléculaires", "item": "https://questionsmedicales.fr/mesh/D015335" }, { "@type": "ListItem", "position": 6, "name": "Sondes d'acide nucléique", "item": "https://questionsmedicales.fr/mesh/D015341" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sondes d'acide nucléique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sondes d'acide nucléique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sondes d'acide nucléique", "description": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?\nQuelles maladies peuvent être détectées avec des sondes ?\nQuel est le principe de fonctionnement des sondes ?\nLes sondes peuvent-elles détecter des mutations génétiques ?\nQuel type d'échantillons est utilisé pour les sondes ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique révèlent-elles des symptômes ?\nPeut-on utiliser des sondes pour surveiller des symptômes ?\nLes sondes peuvent-elles aider à prédire des symptômes ?\nLes sondes sont-elles liées à des symptômes spécifiques ?\nComment les sondes aident-elles à comprendre les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?\nComment les sondes aident-elles à la prévention des maladies ?\nPeut-on utiliser des sondes pour la vaccination ?\nLes sondes peuvent-elles détecter des infections précoces ?\nLes sondes sont-elles utilisées dans les programmes de santé publique ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?\nComment les sondes influencent-elles le choix du traitement ?\nPeut-on développer des traitements basés sur des sondes ?\nLes sondes aident-elles à surveiller l'efficacité des traitements ?\nLes sondes sont-elles utilisées dans les essais cliniques ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sondes d'acide nucléique", "description": "Les sondes d'acide nucléique peuvent-elles causer des complications ?\nQuelles complications peuvent survenir avec des sondes ?\nLes sondes peuvent-elles entraîner des effets secondaires ?\nComment minimiser les complications liées aux sondes ?\nLes sondes sont-elles fiables pour éviter des complications ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sondes d'acide nucléique", "description": "Quels facteurs de risque sont associés à l'utilisation des sondes ?\nLes sondes sont-elles influencées par des facteurs environnementaux ?\nL'âge est-il un facteur de risque pour l'utilisation des sondes ?\nLes habitudes de vie influencent-elles les résultats des sondes ?\nLes sondes sont-elles affectées par des facteurs génétiques ?", "url": "https://questionsmedicales.fr/mesh/D015341?mesh_terms=Platelet+Transfusion&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment les sondes d'acide nucléique sont-elles utilisées en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier des séquences génétiques spécifiques liées à des maladies." } }, { "@type": "Question", "name": "Quelles maladies peuvent être détectées avec des sondes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour détecter des infections virales, bactériennes et des cancers." } }, { "@type": "Question", "name": "Quel est le principe de fonctionnement des sondes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elles se lient spécifiquement à des séquences cibles, permettant leur détection par hybridation." } }, { "@type": "Question", "name": "Les sondes peuvent-elles détecter des mutations génétiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines sondes sont conçues pour identifier des mutations spécifiques dans l'ADN." } }, { "@type": "Question", "name": "Quel type d'échantillons est utilisé pour les sondes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des échantillons de sang, de tissus ou de fluides corporels peuvent être analysés." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique révèlent-elles des symptômes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles détectent des séquences génétiques, pas des symptômes cliniques." } }, { "@type": "Question", "name": "Peut-on utiliser des sondes pour surveiller des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en surveillant des biomarqueurs associés à des symptômes spécifiques." } }, { "@type": "Question", "name": "Les sondes peuvent-elles aider à prédire des symptômes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent indiquer un risque accru de maladies, mais pas de symptômes immédiats." } }, { "@type": "Question", "name": "Les sondes sont-elles liées à des symptômes spécifiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont liées à des maladies, qui peuvent avoir des symptômes variés." } }, { "@type": "Question", "name": "Comment les sondes aident-elles à comprendre les symptômes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles aident à identifier les causes génétiques sous-jacentes des symptômes observés." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique jouent-elles un rôle préventif ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en permettant le dépistage précoce de maladies génétiques ou infectieuses." } }, { "@type": "Question", "name": "Comment les sondes aident-elles à la prévention des maladies ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles permettent d'identifier les individus à risque et de mettre en place des mesures préventives." } }, { "@type": "Question", "name": "Peut-on utiliser des sondes pour la vaccination ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent aider à développer des vaccins en identifiant des cibles immunogènes." } }, { "@type": "Question", "name": "Les sondes peuvent-elles détecter des infections précoces ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont efficaces pour détecter des infections à un stade précoce." } }, { "@type": "Question", "name": "Les sondes sont-elles utilisées dans les programmes de santé publique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont intégrées dans des programmes de dépistage et de surveillance épidémiologique." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique sont-elles utilisées en traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont pas des traitements, mais aident à guider les choix thérapeutiques." } }, { "@type": "Question", "name": "Comment les sondes influencent-elles le choix du traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles identifient des cibles spécifiques, permettant des thérapies ciblées adaptées." } }, { "@type": "Question", "name": "Peut-on développer des traitements basés sur des sondes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements peuvent être développés pour cibler des séquences spécifiques." } }, { "@type": "Question", "name": "Les sondes aident-elles à surveiller l'efficacité des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être utilisées pour évaluer la réponse au traitement au niveau moléculaire." } }, { "@type": "Question", "name": "Les sondes sont-elles utilisées dans les essais cliniques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour évaluer des biomarqueurs dans les essais cliniques." } }, { "@type": "Question", "name": "Les sondes d'acide nucléique peuvent-elles causer des complications ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement sûres, mais des erreurs de diagnostic peuvent entraîner des complications." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des sondes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des faux positifs ou négatifs, affectant le traitement." } }, { "@type": "Question", "name": "Les sondes peuvent-elles entraîner des effets secondaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles n'ont pas d'effets secondaires directs, mais des erreurs peuvent avoir des conséquences." } }, { "@type": "Question", "name": "Comment minimiser les complications liées aux sondes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "En utilisant des protocoles de test rigoureux et en validant les résultats obtenus." } }, { "@type": "Question", "name": "Les sondes sont-elles fiables pour éviter des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement fiables, mais leur précision dépend de la qualité des échantillons." } }, { "@type": "Question", "name": "Quels facteurs de risque sont associés à l'utilisation des sondes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux de maladies génétiques ou infectieuses." } }, { "@type": "Question", "name": "Les sondes sont-elles influencées par des facteurs environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme l'exposition à des agents pathogènes peuvent influencer les résultats." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour l'utilisation des sondes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies détectées par sondes sont plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles les résultats des sondes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme peuvent affecter la santé et les résultats des tests." } }, { "@type": "Question", "name": "Les sondes sont-elles affectées par des facteurs génétiques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des variations génétiques peuvent influencer la sensibilité et la spécificité des sondes." } } ] } ] }

Sources (7103 au total)

Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes.

This study aimed to describe the burden of thrombocytopenia, supportive care practices, bleeding complications and predictors of bleeding in MDS patients within a large Australian hospital network, to... A retrospective cohort study of patients aged ≥18 years with MDS, chronic myelomonocytic leukaemia or MDS/myeloproliferative overlap neoplasm admitted from 2016 to 2018 was conducted. Data were obtain... One hundred seventy-nine patients (median age 78 years, 61.5% male) were identified. The median platelet count at first admission was 90 × 10... Thrombocytopenia is common in MDS. Although guidelines recommend otherwise, prophylactic platelet transfusions were commonly used for severe thrombocytopenia. Despite the majority of patients receivin...

The appropriateness of platelet transfusions in hematological patients and the potential for improvement.

Hematology patients are intensive platelet users. In clinical practice, a substantial proportion of platelet (PLT) transfusions are routinely administered outside the guidelines despite compelling evi... The audit of all PLT orders for adult hematological inpatients was conducted over 2 months. The assessment was performed using guidelines for PLT transfusion. Patient demographic, clinical, and transf... Based on 286 PLT orders, 344 PCs were transfused to 67 patients: 235 (82.2%) prophylactical due to low PLT count, 34 (11.9%) preprocedural and 17 (5.9%) therapeutic. Overall, 105 (36.77%) PLT transfus... Our audit of PLT transfusion practice found a large proportion of inappropriate PLT transfusions. Based on the most common deviations from the guidelines a variety of targeted measures for improvement...

Evaluation of the Association of Platelet Count, Mean Platelet Volume, and Platelet Transfusion With Intraventricular Hemorrhage and Death Among Preterm Infants.

Platelet transfusion is commonly performed in infants to correct severe thrombocytopenia or prevent bleeding. Exploring the associations of platelet transfusion, platelet count (PC), and mean platelet... To evaluate the associations of platelet transfusion, PC, and MPV with IVH and in-hospital mortality and to explore whether platelet transfusion-associated IVH and mortality risks vary with PC and MPV... This retrospective cohort study included preterm infants who were transferred to the neonatal intensive care unit on their day of birth and received ventilation during their hospital stay. The study w... Platelet transfusion, PC, and MPV.... Any grade IVH, severe IVH (grade 3 or 4), and in-hospital mortality.... Among the 1221 preterm infants (731 [59.9%] male; median [IQR] gestational age, 31.0 [29.0-33.0] weeks), 94 (7.7%) received 166 platelet transfusions. After adjustment for potential confounders, plate... In preterm infants, platelet transfusion, PC, and MPV were associated with mortality, and PC was also associated with any grade IVH and severe IVH. The findings suggest that a lower platelet transfusi...

Immunologic effects of red blood cell and platelet transfusions in neonates.

Premature neonates are frequently transfused red blood cells (RBCs) or platelets to raise hemoglobin or platelet counts. However, these transfusions may have unintended effects on the immune system. T... Neonatal RBC transfusions are associated with increases in plasma pro-inflammatory cytokines, but recent findings suggest sex-specific differential responses. At least one cytokine (monocyte chemoattr... RBC and platelet transfusions alter neonatal immune and inflammatory responses. Their pro-inflammatory effects might worsen neonatal disease or affect neurodevelopmental outcomes....

Thromboelastography in guiding preventive platelet transfusion in patients with haematologic diseases.

This study analysed the relationships between the main thromboelastography (TEG) parameters, the platelet (PLT) count and clinical bleeding in patients with blood diseases. We explored the threshold o... In total, 268 patients with clear diagnoses of blood diseases and thrombocytopenia were enrolled and divided into five groups, A, B, C, D and E, corresponding to PLT counts of 0-10 × 10... The maximum amplitude (MA) in groups A, B and C increased gradually, with a significant difference between each pair of these groups (P < 0.05). In groups A, B, C, D and E, the corresponding MA at the... The MA can be used as a reference indicator for preventive PLT transfusion to a certain extent. When the PLT count is within different ranges, the MA threshold for preventive PLT transfusion also diff...

Platelet transfusion in critical care: A new method to analyze transfusion practice based on decision time intervals.

While prior studies of platelet transfusion in critical care have focused on transfusions given, proper analysis of clinical transfusion practice also requires consideration of the decision not to tra... We introduce a new method to assess transfusion practice based on decision time intervals (DTIs). Each patient's intensive care (ICU) stay was segmented into a series of DTIs defined by a time interva... Among 6125 ICU patients treated between October 2016 and October 2021, we analyzed 39,745 DTIs among patients (n = 2921) who had at least one DTI with thrombocytopenia (≤150,000/μL). We found no assoc... DTI analysis represents a new method to assess transfusion practice that considers both transfusions given and not given, and that analyzes clinical circumstances present when decisions regarding tran...

A meta-analysis of risk factors associated with platelet transfusion refractoriness.

Platelet transfusion refractoriness (PTR) remains an intractable issue in clinical practice, and is common in hematological patients. At present, it is believed that both immune and non-immune factors... PubMed, Embase, Cochrane library, and Web of Science were selected as research database platforms. Citations included were further assessed for quality and bias using the Newcastle-Ottawa Scale. All a... The preliminary search revealed 1069 publications, and 17 (5929 patients in total) were ultimately included in the quantitative analysis. The following variables were associated with the occurrence of... We identified some important risk factors for PTR, but further research is needed to identify the many other possible elements that may contribute to or mediate PTR....